Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Horizon Lines: A Quarterly Review of NDAs – October- December 2025
This quarterly review of New Drug Applications contains data for applications approved for the first time during the last quarter of 2025, which includes New Molecular Entities (NMEs) and new biologics. A total of 40 applications were approved by the FDA during these three months. read more
AI in Pharmacovigilance: Key Takeaways from Boehringer Ingelheim’s Recent Rollout
In conversation with Pharmaceutical Outsourcing, Claudia Lehman, Head of Global Pharmacovigilance Operations at Boehringer Ingelheim and Lucinda Smith, ArisGlobal’s Chief Safety Product Officer, reflect on some of the lessons learned from Boehringer’s deployment of AI to date in targeted use cases, starting with adverse event case intake and processing. read more
Quality: The Gold Standard for CDMOs - No Exceptions, No Compromises
In today’s hyper-competitive pharmaceutical landscape, innovation, speed-to-market and cost control usually take the spotlight when selecting a contract development and manufacturing organization (CDMO). However, underneath all those metrics, a single truth remains: if quality fails, so does everything else. read more
Prefilled Syringes: Sterile Drug Delivery, Market Dynamics, CDMO Partnerships, and Market Outlook to 2030
The global pharmaceutical sterile and prefilled syringe market has experienced remarkable growth in recent years, fueled by technological advances and evolving therapeutic needs. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Samsung Biologics Completes Acquisition of GSK’s Manufacturing Facility in Rockville, MD
Tuesday, March 31, 2026
Samsung Biologics announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company’s ... read more
Swiss Rockets Collaborates with Lonza to Advance Torqur’s Oncology Drug Candidate Bimiralisib into Late-Stage Clinical Development
Tuesday, March 31, 2026
Torqur AG, a clinical-stage biotechnology company advancing treatments for oncology and dermatology, and Lonza, a contract development and ... read more
LabConnect Launches Digital Platform to Streamline Clinical Trial Sample Management
Tuesday, March 31, 2026
LabConnect has launched a new digital platform that enables research sites to scan, record, and transmit participant sample data directly from mobile ... read more
Lumicera Health Services Launches Clarventa
Tuesday, March 31, 2026
Lumicera Health Services announced the launch of Clarventa, a new company created to address one of the most persistent drivers of rising ... read more
Symeres and Ambagon Therapeutics Partner on Molecular Glue Research in Colorectal Cancer
Tuesday, March 31, 2026
Symeres has partnered with Ambagon Therapeutics to explore a new class of small molecules, known as molecular glues, for potential use in colorectal ... read more